Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation of titer of antibody to principal neutralizing domain of HIVMN strain with disease progression in Japanese hemophiliacs seropositive for HIV type 1.
Yamanaka T, Fujimura Y, Ishimoto S, Yoshioka A, Konishi M, Narita N, Mimaya J, Meguro T, Nakasone T, Okamoto Y, Yoshizaki H, Yamada K, Honda M. Yamanaka T, et al. Among authors: yoshizaki h. AIDS Res Hum Retroviruses. 1997 Mar 1;13(4):317-26. doi: 10.1089/aid.1997.13.317. AIDS Res Hum Retroviruses. 1997. PMID: 9071431
Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.
Honda M, Matsuo K, Nakasone T, Okamoto Y, Yoshizaki H, Kitamura K, Sugiura W, Watanabe K, Fukushima Y, Haga S, Katsura Y, Tasaka H, Komuro K, Yamada T, Asano T, Yamazaki A, Yamazaki S. Honda M, et al. Among authors: yoshizaki h. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10693-7. doi: 10.1073/pnas.92.23.10693. Proc Natl Acad Sci U S A. 1995. PMID: 7479867 Free PMC article.
Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine.
Chujoh Y, Matsuo K, Yoshizaki H, Nakasatomi T, Someya K, Okamoto Y, Naganawa S, Haga S, Yoshikura H, Yamazaki A, Yamazaki S, Honda M. Chujoh Y, et al. Among authors: yoshizaki h. Vaccine. 2001 Dec 12;20(5-6):797-804. doi: 10.1016/s0264-410x(01)00398-x. Vaccine. 2001. PMID: 11738743
Baicalin, an inhibitor of HIV-1 production in vitro.
Kitamura K, Honda M, Yoshizaki H, Yamamoto S, Nakane H, Fukushima M, Ono K, Tokunaga T. Kitamura K, et al. Among authors: yoshizaki h. Antiviral Res. 1998 Feb;37(2):131-40. doi: 10.1016/s0166-3542(97)00069-7. Antiviral Res. 1998. PMID: 9588845
Human T-lymphotropic virus type II in Japan.
Yoshizaki H, Kitamura K, Oki A, Yahara S, Yamanaka R, Fukushima Y, Komuro K, Yamazaki S, Honda M. Yoshizaki H, et al. Jpn J Cancer Res. 1996 Jan;87(1):1-4. doi: 10.1111/j.1349-7006.1996.tb00191.x. Jpn J Cancer Res. 1996. PMID: 8609039 Free PMC article.
Detection of an HTLV-II-seropositive blood donor in Japan.
Yoshizaki H, Hall WW, Fukushima Y, Oki A, Yamanaka S, Kitamura K, Yamazaki S, Honda M. Yoshizaki H, et al. Vox Sang. 1996;70(2):121-2. doi: 10.1111/j.1423-0410.1996.tb01308.x. Vox Sang. 1996. PMID: 8801764 No abstract available.
97 results